The global End Stage Renal Disease (ESRD) Market size was worth USD 83.4 billion in 2022, with a projected compound annual growth rate of 3.5% during the forecast period. This growth is due to an increasing aging population and a rising prevalence of diabetes, hypertension, and Chronic Kidney Disorders (CKD), which are significant risk factors for ESRD. CKD affects over 37 million Americans and...